Doctor profile · Federal record
Dr. Kwadwo Gyarteng-Dakwa, MD
Pain Medicine (Anesthesiology) Physician (CMS: Anesthesiology) · Durham, NC
- NPI 1285679845
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 36 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2609 N Duke St, Suite 303B
Durham, NC 27704
(919) 220-0107
fax (919) 220-7623
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- August 22, 2024
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207LP2900X — NUCC code
- State license (1)
- North Carolina #200500050
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285679845. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,102
Distinct HCPCS
6
Medicare allowed
$427,511
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,088 | 135 | $122 | |
80307 |
Testing for presence of drug, by chemistry analyzers | 920 | 138 | $60 | |
G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 657 | 128 | $241 | |
G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 326 | 100 | $194 | |
G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 91 | 51 | $153 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 20 | 20 | $161 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 517. This provider delivers 6.0× the peer median.Open Payments
Industry payments received
All-time total
$1,368
Transactions
16
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Curonix LLC | 13 | $1,259.26 | |
| SPR Therapeutics, Inc | 1 | $77.00 | |
| PROTEGA PHARMACEUTIALS INC | 1 | $17.87 | |
| Boston Scientific Corporation | 1 | $14.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
7,589
Patients
1,300
Total drug cost
$422,721
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 2,189 | 262 | $58,702 |
| Cyclobenzaprine Hcl | Generic | 1,060 | 226 | $132,695 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 969 | 149 | $37,214 |
| Diclofenac Potassium | Generic | 489 | 155 | $63,379 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 469 | 68 | $16,585 |
| Tizanidine Hcl | Generic | 408 | 77 | $6,184 |
| Diclofenac Sodium | Generic | 341 | 77 | $11,296 |
| Meloxicam | Generic | 293 | 53 | $1,246 |
| Pregabalin | Generic | 272 | 48 | $9,336 |
| Gabapentin | Generic | 268 | 44 | $5,338 |
Frequently asked questions
What is Dr. Kwadwo Gyarteng-Dakwa's medical specialty?
Dr. Kwadwo Gyarteng-Dakwa practices Pain Medicine (Anesthesiology) Physician in Durham, NC.
Where does Dr. Kwadwo Gyarteng-Dakwa practice?
Dr. Kwadwo Gyarteng-Dakwa practices at 2609 N Duke St, Durham, NC 27704. Office phone: 9192200107.
What is Dr. Kwadwo Gyarteng-Dakwa's NPI?
Dr. Kwadwo Gyarteng-Dakwa's National Provider Identifier (NPI) is 1285679845, issued by NPPES.
Does Dr. Kwadwo Gyarteng-Dakwa accept Medicare assignment?
Yes. Dr. Kwadwo Gyarteng-Dakwa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kwadwo Gyarteng-Dakwa commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS G0483). Source: CMS Medicare Physician & Other Practitioners file.